$18.00
0.31% yesterday
Nasdaq, Oct 15, 10:00 pm CET
ISIN
GB00BY2Z0H74
Symbol
PRTC

PureTech Health Plc - ADR Stock price

$18.00
+2.61 16.96% 1M
+1.32 7.94% 6M
-0.46 2.49% YTD
-2.38 11.66% 1Y
-7.51 29.44% 3Y
-20.50 53.25% 5Y
-20.50 53.25% 10Y
-20.50 53.25% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
+0.06 0.31%
ISIN
GB00BY2Z0H74
Symbol
PRTC
Industry

Key metrics

Basic
Market capitalization
$424.7m
Enterprise Value
$112.7m
Net debt
positive
Cash
$332.9m
Shares outstanding
240.3m
Valuation (TTM | estimate)
P/E
85.7 | negative
P/S
66.5 | -
EV/Sales
17.6 | -
EV/FCF
negative
P/B
1.1
Financial Health
Equity Ratio
68.8%
Return on Equity
12.9%
ROCE
-22.9%
ROIC
-53.2%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$6.4m | $0.0
EBITDA
$-114.2m | $-140.6m
EBIT
$-117.6m | $-145.6m
Net Income
$50.7m | $-145.6m
Free Cash Flow
$-100.3m
Growth (TTM | estimate)
Revenue
1,259.6% | -100.0%
EBITDA
14.0% | -6.1%
EBIT
13.8% | -7.0%
Net Income
161.5% | -372.1%
Free Cash Flow
17.1%
Margin (TTM | estimate)
Gross
-
EBITDA
-1,786.6% | -
EBIT
-1,840.5%
Net
793.0% | -
Free Cash Flow
-1,569.4%
More
EPS
$0.2
FCF per Share
$-0.4
Short interest
0.1%
Employees
90
Rev per Employee
$50.0k
Show more

Is PureTech Health Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

PureTech Health Plc - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a PureTech Health Plc - ADR forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a PureTech Health Plc - ADR forecast:

Buy
80%
Hold
20%

Financial data from PureTech Health Plc - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
6.39 6.39
1,260% 1,260%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 69 69
25% 25%
1,073%
- Research and Development Expense 55 55
32% 32%
867%
-114 -114
14% 14%
-1,787%
- Depreciation and Amortization 3.45 3.45
7% 7%
54%
EBIT (Operating Income) EBIT -118 -118
14% 14%
-1,841%
Net Profit 51 51
161% 161%
793%

In millions USD.

Don't miss a Thing! We will send you all news about PureTech Health Plc - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PureTech Health Plc - ADR Stock News

Neutral
Business Wire
17 days ago
BOSTON--(BUSINESS WIRE)--PureTech Presents New Data from Deupirfenidone Phase 2b Open-Label Extension, Further Supporting Potential to Serve as New Standard of Care in IPF.
Neutral
Seeking Alpha
about 2 months ago
PureTech Health plc (NASDAQ:PRTC ) Q2 2025 Earnings Call August 28, 2025 9:00 AM ET Company Participants Allison Mead Talbot - Senior VP of Communications & Head of Investor Relations Eric Elenko - Co-Founder & President Luba Greenwood - Corporate Participant Robert Lyne - Interim Chief Executive Officer Sven Dethlefs - Corporate Participant Conference Call Participants Heidi Danielle Jacobson ...
Neutral
Business Wire
about 2 months ago
BOSTON--(BUSINESS WIRE)--PureTech today announces its half-yearly results for the six months ended June 30, 2025.
More PureTech Health Plc - ADR News

Company Profile

PureTech Health Plc is a cross-disciplinary bio-pharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune. It operates through the following segments: Internal, and Affiliates. The Internal segment is advancing a pipeline fuelled by recent discoveries in lymphatics and immune cell trafficking to modulate disease in a tissue-specific manner. The Affiliates segment is comprised of the programmes within PureTech's Affiliates division. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

Head office United Kingdom
CEO Bharatt Chowrira
Employees 90
Founded 2015
Website puretechhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today